LLY
734.37
-0.09%↓
JNJ
176.67
-0.01%↓
ABBV
208.05
-0.2%↓
UNH
303.9
+1.02%↑
AZN
79.94
-0.17%↓
LLY
734.37
-0.09%↓
JNJ
176.67
-0.01%↓
ABBV
208.05
-0.2%↓
UNH
303.9
+1.02%↑
AZN
79.94
-0.17%↓
LLY
734.37
-0.09%↓
JNJ
176.67
-0.01%↓
ABBV
208.05
-0.2%↓
UNH
303.9
+1.02%↑
AZN
79.94
-0.17%↓
LLY
734.37
-0.09%↓
JNJ
176.67
-0.01%↓
ABBV
208.05
-0.2%↓
UNH
303.9
+1.02%↑
AZN
79.94
-0.17%↓
LLY
734.37
-0.09%↓
JNJ
176.67
-0.01%↓
ABBV
208.05
-0.2%↓
UNH
303.9
+1.02%↑
AZN
79.94
-0.17%↓
24h
Actual
Mínimo
2.29
Máximo
2.44
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +339.57% upside |
Próximas Ganancias | 12 nov 2025 |
---|
El rendimiento pasado no es un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 10.33 USD 339.57%
Máximo 17 USD
Mínimo 2 USD
De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
3 ratings
2
Comprar
1
Mantener
0
Vender
De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$